(Q37795283)

23 August 2017

title

Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases (English)

1 reference

23 August 2017

0 references

Philip C Hill

1

1 reference

23 August 2017

Martin O C Ota

series ordinal

2

1 reference

23 August 2017

publication date

1 October 2010

1 reference

Lancet Infectious Diseases

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

723-732

1 reference

Risk of Persons in Familial Contact with Pulmonary Tuberculosis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Tuberculosis in Africa: learning from pathogenesis for biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Risk Factors for Tuberculosis Infection in Children in Contact With Infectious Tuberculosis Cases in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Tuberculosis in household contacts of infectious cases in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Mortality in the Children of Tuberculous Households

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Haematological values from a Gambian cohort--possible reference range for a West African population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

FOXP3 gene expression in a tuberculosis case contact study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Genetic susceptibility to tuberculosis in Africans: a genome-wide scan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Field-based random sampling without a sampling frame: control selection for a case-control study in rural Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Vitamin A deficiency and other factors associated with severe tuberculosis in Timor and Rote Islands, East Nusa Tenggara Province, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Vitamin D and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

The interpretation of human hair trace element concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

A refined symptom-based approach to diagnose pulmonary tuberculosis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Childhood pulmonary tuberculosis: old wisdom and new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Implementation of good clinical practice guidelines in vaccine trials in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Regression analysis with clustered data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

GenABEL: an R library for genome-wide association analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Case-control association testing in the presence of unknown relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Eliminating human tuberculosis in the twenty-first century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Adherence to isoniazid preventive chemotherapy: a prospective community based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Investigators' responsibilities for human subjects in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Health seeking behaviour, health system experience and tuberculosis case finding in Gambians with cough

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Reducing the global burden of tuberculosis: the contribution of improved diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Mycobacterium tuberculosis transmission is not related to household genotype in a setting of high endemicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Proportion of tuberculosis transmission that takes place in households in a high-incidence area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Risk factors for positive tuberculin skin test in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Eliminating latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Neutrophil-mediated innate immune resistance to mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Tuberculin Test in Retrospect and Prospect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Acquisition of Streptococcus pneumoniae and Nonspecific Morbidity in Infants and Their Families

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Household transmission of Streptococcus pneumoniae among siblings with acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Nasopharyngeal carriage of pneumococci in Gambian children and in their families

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Genetic Susceptibility to Severe Infection in Families with Invasive Pneumococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Epidemiology and prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Meningococcal colonization and infection in children and their household contacts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

Update on meningococcal disease with emphasis on pathogenesis and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970164-X

7 January 2021

10.1016/S1473-3099(10)70164-X

Identifiers

DOI

1 reference

23 August 2017

1 reference